Renovia Inc. can now proceed with now projects after CEO Marc Beer helped the company to raise $42M. The money will be used to promote products meant for the treatment of pelvic floor disorders, and there is expected to be a significant boost in the new research. The CEO said that a large sum of the money was raised through a series B round while the remainder was collected through venture debt. This is good news for the company which has been exploring various ways to fund its operations and to venture into new markets.
Diagnostic and therapeutic products
Based in Boston, Renovia Inc. is trying to develop the latest diagnostic and therapeutic products that will help over 250,000 women suffering from pelvic floor disorder. The necessity for these programs stems from the fact that these women have been experiencing a lot of difficulties in managing this condition. In addition to that, the doctors who have been trying to help them have had little help from the available products and therefore, it was important to develop something that will cater to these limitations. Their products have been designed after a long period of research.
The Longwood Fund contribution
To raise the money, Renovia had to rely heavily on the Longwood Fund. This is a healthcare company that had earlier invested in Renovia, and therefore, it was instrumental in raising the money. It is this company that joined the B round, and it is through this round that $32 out of the $42 was collected. With such a contribution, there is no doubt that the company has cemented its investment and so, it is going to play a significant role in determining the future of Renovia. There were other players involved in the collection of the funds. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer
A new version of Leva
While announcing the news, CEO Marc Beer said that one of the solutions that the company was going to develop using the money was a new version of Leva. The Leva has been instrumental in the diagnosis and treatment of various conditions, but the company feels that an upgrade would be more ideal. Indeed, their desire is to come up with better solutions that solve new challenges and so, it informs their decisions.
About Marc Beer
Marc Beer is the chairman, Chief Executive Officer, and co-founder of Renovia, a women startup company that develops diagnostic solutions for the treatment of various conditions. He has over 25 years of experience in the industry and has worked with some of the leading companies. In addition to that, Marc has served as a member of the boards of various organizations. It is his vast experience in management that has helped him to get Renovia Inc. to a perfect start by collecting funds on time and ensuring that projects are not interrupted.
Accomplished businessman Marc Beer has recently raised over forty million dollars for his women’s health startup. When beginning this endeavor, Beer pledged a great deal of his experience and wealth to this women’s health startup. He co-founded the startup, called Renovia Inc., to utilize his skill and background in development and commercial experience in the field of pelvic floor disorders of women.
Renovia Inc. was founded in 2016 with the aim of improving diagnosis and treatment for the millions of women that have pelvic floor disorders, hoping to advance their quality of life that has been specific to their condition in the past. Women with pelvic floor disorders, such as urinary tract incontinence, can be grateful to Renovia Inc. for its development of a product pipeline that could potentially utilize an app to visualize and diagnose pelvic movement. Renovia Inc. already boasts an FDA-cleared device called Leva, which not only strengthens pelvic floor muscles, but can also treat a woman’s stress and urinary incontinence.
The recent raising of funds for the company comes from 10 million dollars in venture debt and 32 million in Series B investment. The startup funds will be used to proceed in the research and development of several new products, which will also be aimed toward women that suffer from pelvic floor issues. The products will span from diagnostic to therapeutic means of use, and will all be geared toward solving pelvic floor issues, such as urinary incontinence, that effect over 250 million women throughout the world.
The Series B round welcomed investors such as Ascension Ventures of Missouri, Perceptive Advisors of New York, and, most recently, a healthcare-based investing firm called The Longwood Fund.
Renovia’s CEO Marc Beer states his gratitude toward the healthcare companies investments, and welcomes them on board for the upcoming testing and development. He mentions that he feels his vision of improving the lives of those women effected by pelvic disorders is shared by investors, and is looking forward to innovating the technologies and digital health platforms that will grow the data and knowledge of pelvic floor disorders. Research and gathering of information will not only provide therapeutic treatment to these women, but also has the potential to lower healthcare costs in the long run. Learn more: https://gazetteday.com/2018/10/marc-beer-funding-renovia/
The new products to be released will include four products that are involved in the therapy and diagnosis of pelvic floor disorders, one of which is a new model of the Leva device that is currently on the market from Renovia.
At least 250 million women around the world suffer from women’s health issues like urinary incontinence and other pelvic floor disorders. Renovia, Inc. is a startup focusing on the development of diagnostic and therapeutic treatments that can be used to treat these common health issues in women.
Renovia, Inc. is co-founded by Marc Beer, and this startup company based out of Boston has been working on several new treatment products for pelvic floor disorders. Their first product has already received FDA approval this past April.
Marc Beer has already raised at least $42 million dollars to invest in Renovia by partnering with several healthcare investing firms. Investment firms such as The Longwood Fund invested in Renovia from the start. Leva being Renovia’s first product approved by the FDA, Longwood Fund intends to invest in the next generation Leva model and four more products that are currently being developed and tested.
CEO Marc Beer has stated that the support they have received in funding this healthcare startup has been overwhelming. As CEO, Beer intends to make the vision Renovia and its investors have in the development of healthcare products designed to improve the effects of pelvic floor disorders in women.
CEO Marc Beer also stated that Renovia intends to use their proprietary and innovative technologies to collect data that will help improve the diagnoses and treatments for these specific disorders. This data can greatly improve treatment by eliminating unnecessary procedures which in turn cut down on health care costs for patients and facilities. The products will also generate more data providing better insight on pelvic floor disorders.
Marc Beer currently serves as Co-Founder, CEO, and Chairman of Renovia, Inc. Marc has over 25 years of development experience in this industry. Mr. Beer co-founded Renovia, Inc. along side Ramon Iglesias, M.D. and Yolanda Lorie around August of 2016. He has had several major positions within the pharmaceutical and healthcare industry.
March Beer earned his BS from Miami University. The experience, education, and knowledge Marc Beer possesses has helped him have a successful career within this industry and has propelled his role with this Boston based startup. The future looks bright for Renovia, Inc. Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html
Dr. Mark McKenna has spent years following his passion with the company OVME. Technology is changing almost every industry and he hopes to change aesthetic medicine for patients around the United States. Patients always want the best product available and with the internet being so widespread in use, they know that they have many different options. Dr. Mark McKenna is hoping to bring these options to their fingertips with his OVME app.
OVME’s offices feature state of the art and luxury combined. They are for patients that their cosmetic procedure to be an experience that they look forward to. Every need of the patient is taken into consideration to ensure that they are comfortable and able to relax.
The app that is currently in development by OVME will be the first of its kind that is solely focused on connecting patients to medical professionals that can perform the aesthetic procedures they are wanting. Not only will they be able to message them and make appointments, they will be able to chat in real time over video.
While many people are afraid of the rapid changes that technology is bringing to the medical world, Dr. Mark McKenna is embracing it. Overall, he believes that the outcome of patients will be improved even more as technology continues to progress. While many patients are afraid that computers and other technology will eventually replace humans in many industries, Dr. Mark McKenna believes that this will not happen when it comes to the world of medicine. Instead, technology will enhance the experience of the patient and assist medical professionals in their work.
In the past, house calls from doctors used to be completely normal. Now they are rare, but OVME and Dr. Mark McKenna are hoping to change that. Not only can some procedures be performed in a location that is convenient for the patient like their office or home, they can choose to complete follow-ups through the app. This adds a level of convenience that has never been seen before. With just two devices connected to the internet, a large portion of a patient’s care can be completed online.